Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation

Oncogene

Volumn 24, Issue 34, 2005, Pages 5325-5332

  Rossetti, Stefano ^a   Van Unen, Leontine ^b   Touw, Ivo P ^b   Hoogeveen, André T ^b   Sacchi, Nicoletta ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

AML1 MTG16; Csf1r; Epigenetic regulation; Myelogenesis

Indexed keywords

DNA; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE; HYBRID PROTEIN; MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MYELOID TRANSLOCATED GENE ON CHROMOSOME 16 PROTEIN; PROTEIN; RECEPTOR SUBUNIT; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; AML1 MTG16 PROTEIN, HUMAN; AML1-MTG16 PROTEIN, HUMAN; COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CSF1R GENE; DOWN REGULATION; EPIGENETICS; GENE; GENE REPRESSION; GENE TARGETING; GENE TRANSLOCATION; GENETIC CODE; GENETIC REGULATION; GROWTH INHIBITION; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; GRANULOCYTE PRECURSOR; HUMAN; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DOWN-REGULATION; EPIGENESIS, GENETIC; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE PRECURSOR CELLS; HISTONES; HUMANS; MICE; ONCOGENE PROTEINS, FUSION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 24044458907     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208651     Document Type: Article

References (27)

1. Ahn MY, Huang G, Bae SC, Wee HJ, Kim WY and Ito Y. (1998). Proc. Natl. Acad. Sci. USA, 95, 1812-1817.
2. Baylin S and Bestor TH. (2002). Cancer Cell 1, 299-305.
3. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK and Plass C. (2000). Nat. Genet., 24, 132-138.
4. de Koning JP, Soede-Bobok AA, Schelen AM, Smith L, van Leeuwen D, Santini V, Burgering BM, Bos JL, Lowenberg B and Touw IP. (1998). Blood, 91, 1924-1933.
5. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S and Pelicci PG. (2002). Science, 295, 1079-1082.
6. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J and Drabkin H. (1992). Blood, 80, 1825-1831.
7. Fazi F, Travaglini L, Carotti D, Palitti F, Diverio D, Alcalay M, McNamara S, Miller WH, Coco FL, Pelicci PG and Nervi C. (2005). Oncogene, 24, 1820-1830.
8. Felgner J, Kreipe H, Heidorn K, Jaquet K, Zschunke F, Radzun HJ and Parwaresch MR. (1991). Pathobiology, 59, 293-298.
9. Follows GA, Tagoh H, Lefevre P, Hodge D, Morgan GJ and Bonifer C. (2003). EMBO J., 22, 2798-2809.
10. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y and Ohki M. (1998). Blood, 91, 4028-4037.
11. Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G, Vornlocher HP and Nordheim A. (2003). Blood, 101, 3157-3163.
12. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
13. Hoogeveen AT, Rossetti S, Stoyanova V, Schonkeren J, Fenaroli A, Schiaffonati L, Van Unen L and Sacchi N. (2002). Oncogene, 21, 6703-6712.
14. Jaenisch R and Bird A. (2003). Nat. Genet., 33 (Suppl), 245-254.
15. Kohzaki H, Ito K, Huang G, Wee HJ, Murakami Y and Ito Y. (1999). Oncogene, 18, 4055-4062.
16. Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N and Ohki M. (1993). Blood, 82, 1270-1276.
17. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E and Hiebert SW. (1998). Mol. Cell. Biol., 18, 7176-7184.
18. Meyers S, Downing JR and Hiebert SW. (1993). Mol. Cell. Biol., 13, 6336-6345.
19. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y and Ohki M. (1991). Proc. Natl. Acad. Sci. USA, 88, 10431-10434.
20. Nisson PE, Watkins PC and Sacchi N. (1992). Cancer Genet. Cytogenet., 63, 81-88.
21. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE and Tenen DG. (2001). Nat. Med., 7, 444-451.
22. Rossetti S, Hoogeveen AT and Sacchi N. (2004). Genomics, 84, 1-9.
23. Shi H, Wei SH, Leu YW, Rahmatpanah F, Liu JC, Yan PS, Nephew KP and Huang TH. (2003). Cancer Res., 63, 2164-2171.
24. Tagoh H, Himes R, Clarke D, Leenen PJ, Riggs AD, Hume D and Bonifer C. (2002). Genes Dev., 16, 1721-1737.
25. Zent CS, Mathieu C, Claxton DF, Zhang DE, Tenen DG, Rowley JD and Nucifora G. (1996). Proc. Natl. Acad. Sci. USA, 93, 1044-1048.
26. Zhang DE, Fujioka K, Hetherington CJ, Shapiro LH, Chen HM, Look AT and Tenen DG. (1994). Mol. Cell. Biol., 14, 8085-8095.
27. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW and Tenen DG. (1996). Mol. Cell. Biol., 16, 1231-1240.